Publications
- N-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia2012 | First Faculty of Medicine
- The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress2008 | First Faculty of Medicine
- FADS Polymorphisms Affect the Clinical and Biochemical Phenotypes of Metabolic Syndrome2022 | First Faculty of Medicine
- Pathogenesis and clinical significance of hypolipidemias2021 | First Faculty of Medicine
- Pharmacotherapy of dyslipidemias - an overview of new findings2021 | First Faculty of Medicine
- Lipid preresolution mediators: their therapeutic potential in atherosclerosis2019 | First Faculty of Medicine
- Polymorphisms rs2167444 and rs508384 in the SCD1 Gene Are Linked with High ApoB-48 Levels and Adverse Profile of Cardiometabolic Risk Factors2019 | First Faculty of Medicine
- Antilipolytic effects of nicotinic acid and its metabolites: a pilot study2018 | First Faculty of Medicine
- Desaturases of fatty acids (FADS) and their physiological and clinical implication2016 | First Faculty of Medicine
- Correlations of clinical and biochemical findings in persons with elevated concentrations of apolipoprotein B482016 | First Faculty of Medicine
Loading network view...